Things You Should Know in the Performing Echocardiographic Examination in Patients with COVID-19

키워드

참고문헌 (40)

1. (2020)[URL]
2. Wu Z, "Characteristics of and important lessons from the coronavirus disease 2019(COVID-19)outbreak in China : summary of a report of 72 314 cases from the Chinese center for disease control and prevention", JAMA, 323, pp.1239~1242 (2020)
3. Richardson S, "Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area", JAMA, 323, pp.2052~2059 (2020)
4. Zheng YY, "COVID-19 and the cardiovascular system", Nat Rev Cardiol, 17, pp.259~260 (2020)
5. In-Cheol Kim, "Updates of Cardiovascular Manifestations in COVID-19 – Korean Experience to Broaden Worldwide Perspectives", Korean Circulation Journal, 50(7), pp.543~554 (2020), 대한심장학회[DOI]
6. Guan WJ, "Clinical characteristics of coronavirus disease 2019 in China", N Engl J Med, 382, pp.1708~1720 (2020)
7. Wang D, "Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China", JAMA, 323, pp.1061~1069 (2020)
8. Chen T, "Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study", BMJ, 368, pp.m1091~ (2020)
9. Ruan Q, "Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China", Intensive Care Med, 46, pp.846~848 (2020)
10. Zhang C, "Cytokine release syndrome in severe COVID-19 : interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality", Int J Antimicrob Agents, 55, pp.105954~ (2020)
11. Guo T, "Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019(COVID-19)", JAMA Cardiol, 5, pp.811~818 (2020)
12. Inciardi RM, "Cardiac involvement in a patient with coronavirus disease 2019(COVID-19)", JAMA Cardiol, 5, pp.819~824 (2020)
13. Xu Z, "Pathological findings of COVID-19 associated with acute respiratory distress syndrome", Lancet Respir Med, 8, pp.420~422 (2020)
14. Shi S, "Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China", JAMA Cardiol, 5, pp.802~810 (2020)
15. Gao C, "Association between cardiac injury and mortality in hospitalized patients infected with avian influenza A(H7N9)virus", Crit Care Med, 48, pp.451~458 (2020)
16. Mahajan K, "Cardiac biomarker-based risk stratification algorithm in patients with severe COVID-19", Diabetes Metab Syndr, 14, pp.929~931 (2020)
17. Zhou F, "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study", Lancet, 395, pp.1054~1062 (2020)
18. Arentz M, "Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State", JAMA, 323, pp.1612~1614 (2020)
19. Christ-Crain M, "Use of B-type natriuretic peptide in the risk stratification of community-acquired pneumonia", J Intern Med, 264, pp.166~176 (2008)
20. Mueller C, "Use of B-type natriuretic peptide in the management of acute dyspnea in patients with pulmonary disease", Am Heart J, 151, pp.471~477 (2006)
21. Gao L, "Prognostic value of NT-proBNP in patients with severe COVID-19", Respir Res, 21, pp.83~ (2020)
22. Johri AM, "ASE statement on point-of-care ultrasound during the 2019 novel coronavirus pandemic", J Am Soc Echocardiogr, 33, pp.670~673 (2020)
23. McMahon SR, "Tablet-based limited echocardiography to reduce sonographer scan and decontamination time during the COVID-19 pandemic", J Am Soc Echocardiogr, 33, pp.895~899 (2020)
24. Kluytmans-van den Bergh MF, "Prevalence and clinical presentation of health care workers with symptoms of coronavirus disease 2019 in 2 Dutch hospitals during an early phase of the pandemic", JAMA Netw Open, 3, pp.e209673~ (2020)
25. Lai X, "Coronavirus disease 2019 (COVID-2019) infection among health care workers and implications for prevention measures in a tertiary hospital in Wuhan, China", JAMA Netw Open, 3, pp.e209666~ (2020)
26. Dweck MR, "Global evaluation of echocardiography in patients with COVID-19", Eur Heart J Cardiovasc Imaging, 21, pp.949~958 (2020)
27. DeFilippis AP, "Assessment and treatment of patients with type 2 myocardial infarction and acute nonischemic myocardial injury", Circulation, 140, pp.1661~1678 (2019)
28. Ibanez B, "2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation : the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology(ESC)", Eur Heart J, 39, pp.119~177 (2018)
29. Stefanini GG, "Critical organizational issues for cardiologists in the COVID-19 outbreak: a frontline experience from Milan, Italy", Circulation, 141, pp.1597~1599 (2020)
30. Arrigo M, "Precipitating factors and 90-day outcome of acute heart failure : a report from the intercontinental GREAT registry", Eur J Heart Fail, 19, pp.201~208 (2017)
31. Mehra MR, "Cardiovascular disease, drug therapy, and mortality in COVID-19", N Engl J Med, 382, pp.e102~ (2020)
32. Li B, "Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China", Clin Res Cardiol, 109, pp.531~538 (2020)
33. Huang C, "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China", Lancet, 395, pp.497~506 (2020)
34. Kim IC, "COVID-19-related myocarditis in a 21-year-old female patient", Eur Heart J, 41, pp.1859~ (2020)
35. Medina de Chazal H, "Stress cardiomyopathy diagnosis and treatment : JACC state-of-the-art review", J Am Coll Cardiol, 72, pp.1955~1971 (2018)
36. Templin C, "Clinical features and outcomes of takotsubo(stress)cardiomyopathy", N Engl J Med, 373, pp.929~938 (2015)
37. Lyon AR, "Current state of knowledge on Takotsubo syndrome : a position statement from the taskforce on Takotsubo syndrome of the Heart Failure Association of the European Society of Cardiology", Eur J Heart Fail, 18, pp.8~27 (2016)
38. Pilgrim TM, "Takotsubo cardiomyopathy or transient left ventricular apical ballooning syndrome : a systematic review", Int J Cardiol, 124, pp.283~292 (2008)
39. Dabbagh MF, "Cardiac tamponade secondary to COVID-19", JACC Case Rep, 2, pp.1326~1330 (2020)
40. Driggin E, "Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic", J Am Coll Cardiol, 75, pp.2352~2371 (2020)

관련 논문AI추천